On 5th February 2020, HELIX IMMUNO-ONCOLOGY S.A. submitted the following documents related to the financial year lasting from 1st August 2018 to 31st July 2019 at the Repository of Financial Documents:
- Financial statement,
- Report on business activities,
- Auditor’s opinion / report on the audit of the annual financial statement
- Resolution on allocation of profit or loss coverage,
- Resolution on approval of the annual financial statement.